The role of intellectual property rights in biotechnology innovation edited by David Castle
ISBN
9781847209801(pbk.)
พิมพ์ลักษณ์
Cheltenham, UK : E. Elgar, c2009.
เลขหมู่
K1519.B54 R745 2009
ลักษณะทางกายภาพ
xiv, 459 p. : ill. ; 24 cm.
หมายเหตุ
Papers from a workshop held in the fall of 2005 at the Robert Schumann Centre for International Studies at the European University Institute in Florence, Italy
หมายเหตุ
Contents: Are intellectual property rights quanta of innovation?/ J. Adam Holbrook -- Intellectual property rights and innovation systems : issues for governance in a global context/ Bjorn Asheim, Finn Valentin and Christian Zeller -- Intellectual property rights policy for gene-related inventions : toward optimum balance between public and private ownership/ Koichi Sumikura -- Fundamentals of intellectual property management/ Patrick H. Sullivan -- Making a return on R&D : a business perspective/ Sharon Oriel -- Looking beyond the firm : intellectual asset management and biotechnology/ Karen L. Durell and E. Richard Gold -- Increasing internal value from patents : the role of organizational arrangements/ Marc Ingham, Cecile Ayerbe, Emmanuel Métais and Liliana Mitkova -- Language system (LS) 3.0 : an agenda for a model of innovation valuation/ Clinton W. Francis -- Measurement of innovation and intellectual property management : challenging processes/ L. Martin Cloutier and Susanne Sirois -- Open development : is the 'open source' analogy relevant to biotechnology?/ Alan G. Isaac and Walter G. Park -- On the border : biotechnology, the scope of intellectual property and the dissemination of scientific benefits/ Christopher May.
245 04 ^aThe role of intellectual property rights in biotechnology innovation /^cedited by David Castle
260 ^aCheltenham, UK :^bE. Elgar, ^cc2009.
300 ^axiv, 459 p. :^bill. ;^c24 cm.
500 ^aPapers from a workshop held in the fall of 2005 at the Robert Schumann Centre for International Studies at the European University Institute in Florence, Italy
504 ^aIncludes bibliographical references and index
505 0 ^aAre intellectual property rights quanta of innovation?/^rJ. Adam Holbrook -- ^tIntellectual property rights and innovation systems : issues for governance in a global context/^rBjorn Asheim, Finn Valentin and Christian Zeller -- ^tIntellectual property rights policy for gene-related inventions : toward optimum balance between public and private ownership/^rKoichi Sumikura -- ^tFundamentals of intellectual property management/^rPatrick H. Sullivan -- ^tMaking a return on R&D : a business perspective/^rSharon Oriel -- ^tLooking beyond the firm : intellectual asset management and biotechnology/^rKaren L. Durell and E. Richard Gold -- ^tIncreasing internal value from patents : the role of organizational arrangements/^rMarc Ingham, Cecile Ayerbe, Emmanuel Métais and Liliana Mitkova -- ^tLanguage system (LS) 3.0 : an agenda for a model of innovation valuation/^rClinton W. Francis -- ^tMeasurement of innovation and intellectual property management : challenging processes/^rL. Martin Cloutier and Susanne Sirois -- ^tOpen development : is the \'open source\' analogy relevant to biotechnology?/^rAlan G. Isaac and Walter G. Park -- ^tOn the border : biotechnology, the scope of intellectual property and the dissemination of scientific benefits/^rChristopher May.
650 0 ^aBiotechnology^vCongresses
650 0 ^aBiotechnology^xLaw and legislation^vCongresses